Literature DB >> 666624

Progressive chorioretinopathy after receiving thioridazine.

T A Meredith, T M Aaberg, W D Willerson.   

Abstract

A distinctive appearance of the ocular fundus as a late complication of high doses of orally administered thioridazine hydrochloride (Mellaril) is described. Discrete nummular areas of loss of retinal pigment epithelium (RPE) extended from the posterior pole to the midperiphery. Fluorescein angiography demonstrated loss of choriocapillaris in these zones. Atrophy of the remaining RPE was progressive, with advancement of the edges of the atrophic zones and breakdown of bridges of RPE separating them. Atrophy occurred after discontinuation of the drug and advanced without further exposure to it. Dark adaptation, the electroretinogram, and the electro-oculogram were abnormal in the late stages. Central visual acuity remained relatively good.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 666624     DOI: 10.1001/archopht.1978.03910060006002

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  10 in total

Review 1.  Ocular adverse effects of neuropsychiatric agents. Incidence and management.

Authors:  T Oshika
Journal:  Drug Saf       Date:  1995-04       Impact factor: 5.606

2.  Schizophrenia and the retina: Towards a 2020 perspective.

Authors:  Steven M Silverstein; Samantha I Fradkin; Docia L Demmin
Journal:  Schizophr Res       Date:  2019-11-07       Impact factor: 4.939

Review 3.  Ocular adverse effects of common psychotropic agents: a review.

Authors:  Sami Richa; Jean-Claude Yazbek
Journal:  CNS Drugs       Date:  2010-06       Impact factor: 5.749

4.  Ocular toxicity from systemic drug therapy. An overview of clinically important adverse reactions.

Authors:  S I Davidson; I G Rennie
Journal:  Med Toxicol       Date:  1986 May-Jun

5.  Pigmentary retinopathy associated with low-dose thioridazine treatment.

Authors:  R W Lam; R A Remick
Journal:  Can Med Assoc J       Date:  1985-04-01       Impact factor: 8.262

Review 6.  Adverse ocular reactions to drugs.

Authors:  M A Spiteri; D G James
Journal:  Postgrad Med J       Date:  1983-06       Impact factor: 2.401

7.  Is thioridazine retinopathy progressive? Relationship of pigmentary changes to visual function.

Authors:  M F Marmor
Journal:  Br J Ophthalmol       Date:  1990-12       Impact factor: 4.638

8.  Functional visual loss.

Authors:  Beau B Bruce; Nancy J Newman
Journal:  Neurol Clin       Date:  2010-08       Impact factor: 3.806

Review 9.  Clinically important ocular reactions to systemic drug therapy.

Authors:  I G Rennie
Journal:  Drug Saf       Date:  1993-09       Impact factor: 5.606

Review 10.  Wide field retinal imaging and the detection of drug associated retinal toxicity.

Authors:  Giulia Corradetti; Sara Violanti; Adrian Au; David Sarraf
Journal:  Int J Retina Vitreous       Date:  2019-12-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.